Showing results (1-10 of 713) with videos related to
Sort By:
Pageof 72
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Kinase inhibitor selectivity profiling using differential scanning fluorimetryOleg Fedorov, Frank H Niesen, Stefan KnappStructure (London, England : 1993)|August 15, 2009
Out of the box binding determines specificity of SH2 domain interactionSusanne Müller, Stefan KnappExpert Opinion on Drug Discovery|July 25, 2012
Targeting kinases for the treatment of inflammatory diseasesSusanne Müller, Stefan KnappJournal of Medicinal Chemistry|September 28, 2016
Development of Selective CBP/P300 Benzoxazepine Bromodomain InhibitorsTobias A Popp, Cynthia Tallant, Catherine Rogers, et al.Drug Discovery Today|May 1, 2007
Insights for the development of specific kinase inhibitors by targeted structural genomicsOleg Fedorov, Michael Sundström, Brian Marsden, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesOleg Fedorov, Brian Marsden, Vanda Pogacic, et al.Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Annotation of the Effect of Chemogenomic Compounds on Cell Health Using High-Content Microscopy in Live-Cell ModeAmelie Tjaden, Stefan Knapp, Susanne MüllerCurrent Opinion in Structural Biology|November 21, 2009
SH2 domains: modulators of nonreceptor tyrosine kinase activityPanagis Filippakopoulos, Susanne Müller, Stefan KnappJournal of Medicinal Chemistry|January 6, 2016
Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor BromodomainApirat Chaikuad, Steffen Lang, Paul E Brennan, et al.Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell ImagingLewis Elson, Amelie Tjaden, Stefan Knapp, et al.Pageof 72